Number of items: 1.
2022
Pal, Sumanta K.,
Somford, Diederik M.,
Grivas, Petros,
Sridhar, Srikala S.,
Gupta, Shilpa,
Bellmunt, Joaquim,
Sonpavde, Guru,
Fleming, Mark T.,
Lerner, Seth P.,
Loriot, Yohann,
Hoffman-Censits, Jean,
Valderrama, Begoña P.,
Andresen, Corina,
Schnabel, Marco J.,
Cole, Suzanne and
Daneshmand, Siamak
(2022)
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial.
Future Oncology 18 (21), pp. 2599-2614.
Fulltext not available.
This list was generated on Mon Dec 2 12:13:28 2024 CET.